[Hypertrophic miocardiopathy. An historical and anatomopathological review]

Manlio F Márquez1, Teresita de Jesús Ruíz-Siller1, Rosario Méndez-Ramos1

  • 1Departamento de Electrofisiología, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, México.

Gaceta Medica De Mexico
|October 30, 2016
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) is a heart condition causing abnormal left ventricle thickening. This review details its characteristics, symptoms, and sudden cardiac death risks, highlighting Iberoamerican research contributions.

Area of Science:

  • Cardiology
  • Pathology

Background:

  • Hypertrophic cardiomyopathy (HCM) is defined by unexplained left ventricular hypertrophy.
  • It can present with or without left ventricular outflow tract obstruction.
  • Key concerns include symptom development and sudden cardiac death risk due to arrhythmias.

Purpose of the Study:

  • To review the historical contributions of Iberoamerican researchers to understanding HCM.
  • To summarize current knowledge on HCM's anatomopathological features.
  • To discuss myofiber disarray as a primary histopathologic characteristic.

Main Methods:

  • Literature review focusing on Iberoamerican contributions to HCM research.
  • Analysis of historical and contemporary anatomopathological findings in HCM.
  • Synthesis of information on clinical manifestations and histopathology.

Main Results:

  • HCM involves abnormal left ventricular thickening without other causes.
  • Outflow tract obstruction and ventricular arrhythmias are significant clinical aspects.
  • Myofiber disarray is identified as a key histopathologic feature.

Conclusions:

  • HCM is a primary cardiac condition with distinct pathological features.
  • Understanding its history and pathology is crucial for diagnosis and management.
  • Iberoamerican research has significantly advanced HCM knowledge.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
607
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
744
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
571
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
700
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
526